Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
FULC

Updated 10/6/2026, 9:41 AM ET.

FULC

Fulcrum Therapeutics, Inc.

Buy$594,675

TANG KEVIN

10% owner

and 1 other

167,616 shat $3.55Filed Jul 20, 9:10 PM ETFiling
FULC

Fulcrum Therapeutics, Inc.

Buy$891,067

TANG KEVIN

10% owner

and 1 other

249,946 shat $3.57Filed Jul 15, 7:50 PM ETFiling

Read from public SEC filings. Not financial advice.